Edition:
United Kingdom

Adaptimmune Therapeutics PLC (ADAP.OQ)

ADAP.OQ on NASDAQ Stock Exchange Global Select Market

4.86USD
18 Jan 2019
Change (% chg)

$-0.18 (-3.57%)
Prev Close
$5.04
Open
$5.04
Day's High
$5.05
Day's Low
$4.74
Volume
137,924
Avg. Vol
148,472
52-wk High
$14.62
52-wk Low
$3.60

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.32 December 19 Jan 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 3 3 3 4
(3) HOLD 2 2 2 1
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.11 2.11 2.11 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 5 2.80 5.00 0.00 --
Quarter Ending Jun-19 5 2.00 5.00 0.00 --
Year Ending Dec-19 8 22.25 65.00 0.00 16.42
Earnings (per share)
Quarter Ending Mar-19 3 -0.32 -0.26 -0.36 --
Quarter Ending Jun-19 3 -0.33 -0.30 -0.36 --
Year Ending Dec-19 6 -1.18 -0.94 -1.45 -1.46
LT Growth Rate (%) 1 1.00 1.00 1.00 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 33.03 40.79 7.76 23.51
Quarter Ending Jun-18 8.71 9.04 0.33 3.77
Quarter Ending Mar-18 9.10 8.20 0.91 9.96
Quarter Ending Dec-17 8.56 4.27 4.29 50.10
Quarter Ending Sep-17 6.26 27.18 20.93 334.54
Earnings (per share)
Quarter Ending Sep-18 -0.05 0.06 0.12 -209.09
Quarter Ending Jun-18 -0.27 -0.48 0.21 -75.63
Quarter Ending Mar-18 -0.24 -0.22 0.02 -8.98
Quarter Ending Dec-17 -0.23 -0.30 0.07 -31.41
Quarter Ending Sep-17 -0.23 -0.01 0.22 -96.03

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 2.80 2.80 2.25 2.25 --
Quarter Ending Jun-19 2.00 2.00 1.25 1.25 --
Year Ending Dec-19 22.25 22.25 22.25 22.25 16.42
Earnings (per share)
Quarter Ending Mar-19 -0.32 -0.32 -0.32 -0.32 --
Quarter Ending Jun-19 -0.33 -0.33 -0.33 -0.33 --
Year Ending Dec-19 -1.18 -1.18 -1.18 -1.18 -1.46

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 0 0 0 0
Quarter Ending Jun-19 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings
Quarter Ending Mar-19 0 0 0 0
Quarter Ending Jun-19 0 0 0 0
Year Ending Dec-19 0 0 1 0